Aeva Technologies CEO Soroush Salehian Dardashti sold 488,160 shares worth $6.3 million on January 2, 2026, at $12.96 per share. This was his largest single direct sale to date, representing 11.61% of his holdings. The stock has since risen 56%, and the company recently announced a partnership with Nvidia for its 4D LiDAR technology in autonomous vehicle platforms.

Aeva Technologies reported strong Q2 2025 financial results with record revenue of $5.5 million, up 175% year-over-year, and improved non-GAAP earnings. The company is focusing on scaling its LiDAR technology across automotive, industrial, and smart infrastructure markets.

The autonomous vehicle market is evolving with Waymo and Tesla leading driverless taxi services. LiDAR technology is crucial for precise navigation, with companies like Aeva and Mobileye developing advanced systems for autonomous vehicles.

Luminar Technologies, a lidar producer, has faced challenges since its public debut, including overpromising and underdelivering. However, with the growing autonomous vehicle market and its unique technology, it could be a contrarian play for the next three years, though its high valuation and lack of profitability remain concerns.

Luminar Technologies, a lidar developer, went public through a SPAC merger in 2017 but has since struggled with overpromising and underdelivering. While the company has strong partnerships and growth potential, it faces competition and profitability challenges. The article suggests Luminar could be an interesting turnaround play, but investors should be cautious due to its speculative nature.

The report provides an in-depth analysis of the rapidly evolving silicon photonics industry, covering market trends, technological developments, and growth opportunities from 2025 to 2035. It examines the convergence of optical and electronic technologies and how silicon photonics is revolutionizing data centers, telecommunications, sensing applications, and emerging quantum computing solutions.

The heavy selling pressure might have exhausted for Aeva Technologies (AEVA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Here is how Aeva Technologies, Inc. (AEVA) and Ferrari (RACE) have performed compared to their sector so far this year.

Shares of SurgePays, Inc. (NASDAQ: SURG) fell sharply in today’s pre-market trading after the company reported worse-than-expected fourth-quarter financial results. Surgepays posted GAAP earnings of 19 cents per share, missing market estimates of 41 cents per share. The company’s quarterly sales came in at $32.318 million versus expectations of $33.521 million, according to data from Benzinga Pro. SurgePays shares dipped 14.6% to $5.97 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers NuCana plc (NASDAQ: NCNA) gained 99.6% to $0.7806 in pre-market trading after the company was granted U.S. Patent #11925658 for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance" ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 50% to $4.71 in pre-market trading after dipping over 19% on Tuesday. Tenon Medical, Inc. (NASDAQ: TNON) rose 48.2% to $2.15 in pre-market trading after the company reported better-than-expected fourth-quarter GAAP EPS results. Minim, Inc. (NASDAQ: MINM) gained 39.8% to ...

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. Asana reported quarterly losses of 4 cents per share which beat the analyst consensus estimate of losses of 10 cents by 60%. Quarterly sales came in at $171.1 million, beating the analyst consensus estimate of $167.676 million by 2.04%. The company expects fiscal year 2025 adjusted losses of between 22 cents and 19 cents per share, versus the losses of 22 cents estimate and fiscal year revenues of between $716 million and $722 million, versus the $724.75 estimate. Asana shares dipped 11% to $16.72 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers ClearOne, Inc. (NASDAQ: CLRO) rose 168.4% to $2.4299. ClearOne announced a special one-time cash dividend of 50 cents per share. Regulus Therapeutics Inc. (NASDAQ: RGLS) climbed 74.3% to $2.4050 after the company announced topline results from the second cohort of patients in its Phase 1b MAD study of RGLS8429 for the treatment of ADPKD. The company announced an oversubscribed $100 million private placement of equity. Assure Holdings Corp. (NASDAQ: IONM) gained 49% to $0.4880. Assure Holdings entered into an agreement to sell certain of its assets to MPOWERHealth for up to $4.5 million. Ranpak Holdings Corp. (NASDAQ: PACK) shares gained 40.1% to $6.12 after the company reported better-than-expected fourth-quarter revenue results and issued FY24 guidance. Also, Baird maintained an Outperform rating on the stock and raised its price target from $5 to $7. Singularity Future Technology Ltd. (NASDAQ: SGLY) climbed 37.6% to $4.3321 after gaining over 6% on Monday. Li-Cycle Holdings Corp. (NASDAQ: LICY) gained 27.4% to $0.5111 after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore. Nukkleus Inc. (NASDAQ: NUKK) shares rose 22.5% to $1.41 after surging over 43% on Monday. ATRenew Inc. (NYSE: RERE) gained 17.7% to $1.4003 after the company ...

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday. Shares of ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) fell sharply in today’s pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not meet the primary endpoint. ACADIA Pharmaceuticals shares dipped 17.4% to $19.93 in pre-market trading. Here are some big stocks recording losses in today’s pre-market trading session. Power & Digital Infrastructure Acquisition II Corp. (NASDAQ: XPDB) shares tumbled 12.6% to $25.57 in pre-market trading after surging ...

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. Marvell said fourth-quarter revenue increased 1% year-over-year to $1.427 billion, which beat the consensus estimate of $1.42 billion. The chip designer reported quarterly earnings of 46 cents per share, which was in line with analyst estimates. Marvell sees first-quarter revenue of $1.15 billion, plus or minus 5%, versus estimates of $1.371 billion. The company sees first-quarter adjusted earnings of 23 cents per share, plus or minus 5 cents per share, versus estimates of 40 cents per share. The company authorized a $3 billion buyback. Marvell Technology shares dipped 9.6% to $76.91 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Ainos, Inc. (NASDAQ: AIMD) jumped 140% to $2.6899 after dipping 18% on Thursday. Psyence Biomedical Ltd. (NASDAQ: PBM) shares climbed 139% to $3.0350. Psyence Biomedical recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study. Safe and Green Development Corporation (NASDAQ: SGD) shares jumped 138% to $1.57 after the company announced financing for the Norman Berry Expansion in Atlanta, Georgia. MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) shares climbed 48.5% to $1.36. MIRA Pharmaceuticals, last month, announced a research collaboration with Pharmaseed to research and evaluate Ketamir for patients with major depressive disorder and post-traumatic stress disorder. CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) shares climbed 35.4% to $4.17 after surging over 20% on Thursday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients. Willdan Group, Inc. (NASDAQ: WLDN) gained 30.4% to $25.89 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. Also, the company secured a contract worth approximately $30 million to $50 million over three years. The Joint Corp. (NASDAQ: JYNT) gained 29% to $11.80 following fourth-quarter results. Smith & Wesson Brands, Inc. (NASDAQ: SWBI) jumped 25.8% to $16.91 after the company reported better-than-expected third-quarter financial results. Research Frontiers Incorporated ...